Pharmaceuticals
Company Overview of Agios Pharmaceuticals, Inc.
Executive Profile
Matthew Vander Heiden M.D., Ph.D.Member of Scientific Advisory Board, Agios Pharmaceuticals, Inc. |
| Age | Total Calculated Compensation | This person is connected to 1 Board Members in 1 different organizations across 1 different industries. See Board Relationships |
| -- | -- |
Background
Matthew Vander Heiden, M.D., Ph.D serves as Instructor of Medicine, Dana Farber Cancer Institute and Harvard Medical School. Dr. Vander Heiden is recognized as one of the leading experts in the field of cancer metabolism. As a clinical fellow in the laboratory of Lewis Cantley, Ph.D. at Beth Israel Deaconess Medical Center, he participated in the identification of pyruvate kinase M2 regulating glucose metabolism in proliferating cells, as published in the journal Nature. ...
Corporate Headquarters38 Sidney StreetCambridge, Massachusetts 02139-4169 United States Phone: 617-649-8600 Fax: -- Board Members MembershipsThere is no Board Members Memberships data available.EducationPhD The University of Chicago BS The University of Chicago MD The University of Chicago
Other Affiliations |
Annual CompensationThere is no Annual Compensation data available.Stocks OptionsThere is no Stock Options data available.Total CompensationThere is no Total Compensation data available. |
COMPETITOR COMPENSATION
| There is no Competitor Compensation data available. |
Post a JobJobs
- Greenville, NC | Vidant Medical CenterPosted: May 15
- New Brunswick, NJ | Tridiagonal SolutionsPosted: Apr 24
- Field, KY | Shire PharmaceuticalsPosted: May 18
- Field, KY | Shire PharmaceuticalsPosted: May 18
Sponsored Financial Commentaries
Sponsored Links
To contact Agios Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








